Navigation Links
Bart Peterson to Join Lilly Leadership Team
Date:6/5/2009

Former Indianapolis Mayor to join Lilly as senior vice president of corporate affairs and communications

INDIANAPOLIS, June 5 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Bart Peterson will be joining Lilly as senior vice president of corporate affairs and communications, reporting directly to chairman, president and chief executive officer John C. Lechleiter, Ph.D. He will be a member of the company's executive and the operations committees.

Peterson will lead an organization that is responsible for international, federal, and state government relations; advocacy and professional relations; public policy planning and development; external and internal communications; pricing, reimbursement, and access; corporate social responsibility; branding; anti-counterfeiting; health information technology coordination; and community and public relations. A significant part of his new role will be leading the company's interactions with the public health sector and other payers worldwide. This includes leading Lilly's effort to support reform of the U.S. health care system.

"Bart is a proven leader with a strong list of achievements. His strategic approach, intellect, and political acumen will make him a valuable addition to Lilly's leadership team," said Lechleiter. "Bart's unique public service and private sector perspectives and experiences will enrich our thinking across a broad range of business issues. He joins Lilly's top leadership at an important moment in time when Lilly and the pharmaceutical industry face significant challenges both in the U.S. and abroad."

Peterson brings to Lilly a distinguished record of leadership and achievement in both the public and private sectors. Peterson served two terms as mayor of Indianapolis (1999 - 2007), where, among many accomplishments, he championed the formation of charter schools. He was also instrumental in the effort that led to the creation of BioCrossroads to promote the development of life sciences businesses in the region. Peterson's public sector experience also includes serving as chief of staff for then Governor of Indiana Evan Bayh.

Prior to being elected mayor of Indianapolis, Peterson was president of The Precedent Companies (1995 - 1999), a commercial and residential real estate development and financial services company in Indianapolis.

More recently, Peterson served a semester as resident fellow in the Kennedy School of Government at Harvard University; taught graduate-level classes on city government and community planning at Ball State University; was managing partner of an urban redevelopment fund for Strategic Capital Partners, LLC; and served a one-year appointment as an urban fellow to consult and advise Living Cities, a New York-based organization that promotes real estate and human development in communities of poverty.

Peterson chaired the U.S. Conference of Mayors committee on arts, culture, and recreation from 2002 - 2005. He also served as president of the National League of Cities from 2006 - 2007. In 2006 his charter school initiative received Harvard's prestigious Innovations in American Government Award, recognizing Indianapolis as a national model for improving public education.

"Throughout his career, Bart has worked tirelessly to make the state of Indiana and the city of Indianapolis better places, and in doing so displayed the kind of vision and decisive action that we must demonstrate to be successful at Lilly," said Lechleiter. "He is a thoughtful, persuasive problem-solver, highly regarded in government circles, and an outstanding communicator. He is also a man of integrity. I am very excited to add him to our executive team."

"Lilly is not only the premier company in Indianapolis and Indiana, more importantly, it is a company that improves the lives of people across the globe through the pharmaceuticals it makes and its comprehensive focus on patient well-being," said Peterson. "I cannot imagine a better, more fulfilling opportunity than to be a part of this cause. I'm excited to join Lilly's leadership team and contribute to spreading the incredible story the company has to tell about the value of our medicines."

A lifelong Indianapolis resident, Peterson earned a B.A. in Political Science from Purdue University. After graduating from Purdue, he attended the University of Michigan Law School (J.D., with honors). He practiced law in Indianapolis prior to joining Governor Bayh's administration.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VITAS Innovative Hospice Care(R) Names Karen Peterson Vice President and Chief Nursing Officer
2. Aflac Celebrates With Petersons Harley Davidson of Miami as 100,000th Online Billing Customer
3. Peter G. Peterson Commits $1 Billion Toward Solving Americas Most Significant Economic Challenges
4. Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Childrens Health Care
5. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
6. Shameful Votes Today on Childrens Health Care by Reps. John Peterson, Joe Pitts and Bill Shuster
7. Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
8. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
9. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
10. Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management
11. Lilly to Celebrate Second Annual Global Day of Service May 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: